Long-Acting Antiretroviral Therapy for HIV via Drop-in Community-Based Care - Summary - MDSpire

Long-Acting Antiretroviral Therapy for HIV via Drop-in Community-Based Care

  • By

  • Nicky J. Mehtani

  • Stephen J. Matzat

  • Kathleen B. O’Connor

  • Laura Cordoba

  • Sarah Strieff

  • Alix Strough

  • Morgan M. Philbin

  • Mallory O. Johnson

  • Monica Gandhi

  • Barry Zevin

  • June 26, 2026

  • 0 min

Share

Objective:

To evaluate the integration of long-acting antiretroviral therapy (LA-ART) at the Maria X. Martinez Health Resource Center for individuals experiencing homelessness from November 2021 to October 2025.

Approach:
  • Patient Population: The study included patients receiving LA-ART from November 2021 to October 2025 and those with 2 or more medical visits between January 2023 and December 2024.
Key Findings:
  • The MXM Health Resource Center served 4424 adults experiencing homelessness in the 2023-2024 fiscal year.
  • Patients included 66% cisgender men, 30% cisgender women, and 3% transgender or nonbinary individuals.
  • 28% identified as Black, 18% as Hispanic or Latine, and 52% as White.
Interpretation:

The study highlights the potential for LA-ART to be effectively integrated into community-based settings for individuals facing significant barriers to traditional HIV care.

Limitations:
  • The study was exempt from IRB review, limiting the depth of ethical oversight.
  • Data were collected retrospectively, which may affect the reliability of outcomes.
Conclusion:

The integration of LA-ART in community-based clinics may improve access to HIV treatment for individuals experiencing homelessness.

Original Source(s)

Related Content